Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Peritoneal Dialysis Patients More Satisfied with Their Care

By HospiMedica staff writers
Posted on 25 Feb 2004
A study has found that kidney disease patients who used peritoneal dialysis at home were 1.5 times more likely to rate their care as excellent than patients who used hemodialysis equipment at a dialysis center. More...
The findings were published in the February 11, 2004, issue of the Journal of the American Medical Association (JAMA).

Hemodialysis patients must spend three to four hours, three times a week, attached to a blood-cleaning machine at a dialysis center. Peritoneal dialysis patients, in contrast, can perform the 30-minute procedure four times a day outside the center on portable equipment, after training, and need to return to the center only monthly for checkups. Peritoneal dialysis involves surgically and permanently placing a soft plastic tube or catheter into the lining of the belly. A sterile cleansing fluid is flushed through the catheter and allowed to dwell in the belly until wastes pass across the lining into the fluid. Once filled with wastes, the fluid is then removed from the belly via the same catheter.

In the study, researchers surveyed 656 patients at dialysis centers. The results showed that 85% of peritoneal dialysis patients rated their care as "excellent,” compared to only 56% of hemodialysis patients. Currently, only 10% of the more than 100,000 patients starting dialysis each year use peritoneal dialysis. The researchers speculate that the pressure to fill large, hemodialysis centers nationwide may be part of the reason for this, as well as lack of information provided on peritoneal dialysis.

"Our study suggests that the vast majority of patients undergoing hemodialysis could be making a decision on dialysis treatment on the basis of very inadequate information,” said Haya Rubin, M.D., Ph.D., professor of medicine at Johns Hopkins Medical Institutions (Baltimore, MD, USA) and a member of the research team.




Related Links:
Johns Hopkins

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.